Meera R. Hameed, MD


Chief, Surgical Pathology Service

Conditions Treated

Meera R. Hameed, MD
LocationA pin, used as a metaphor for the concept of location. Locations Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. Phone Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

About Me

I am a pathologist with expertise in surgical pathology, molecular pathology, and clinical cytogenetics.

As a surgical pathologist, my particular expertise is bone and soft tissue (musculoskeletal) pathology. I work very closely with my clinical colleagues — including surgeons, radiologists, and medical oncologists. This collaboration has given me an in-depth understanding of clinical situations and has provided me the opportunity to participate as a team member with my clinical colleagues. I am an Invited Member of the International Skeletal Society — an organization of radiologists, pathologists, and surgeons who meet yearly to discuss rare and unusual presentations of the various bone and soft tissue neoplasms. I am also interested in teaching, and am a course co-director for orthopedic pathology at meetings of the U.S. and Canadian Academy of Pathology.

I am also a molecular pathologist with board certification in molecular genetic pathology, which allows me to keep abreast of latest developments in the fast-growing field of molecular oncology. As an invited member of the Molecular Oncology Committee of the College of American Pathologists, I serve as the committee member for the sarcoma sub-division and provide expertise on test development and appropriate molecular testing for sarcoma patients.

Clinical cytogenetics, in which I am also board certified, is a field where one studies chromosomal changes to interpret and provide pathological diagnostic correlations. My research involves exploring prognostic markers in bone and soft tissue neoplasms. For example, we have studied expression of markers with therapeutic significance, such as the EGFR family of tyrosine kinases in synovial sarcomas and osteosarcomas.

  • Clinical Expertise: Surgical Pathology; Molecular Diagnostics
  • Languages Spoken: English
  • Education: MD, Kilpaul Medical College Hospital (India)
  • Residencies: Kilpauk Medical College Hospital; Southern Railway Headquarters (India); Hahnemann University Hospital
  • Fellowships: University of Connecticut Health Center; Hahnemann University Hospital; Memorial Sloan Kettering Cancer Center
  • Board Certifications: Anatomic and Clinical Pathology; Molecular Genetic Pathology; Clinical Cytogenetics


Barbashina, V., Benevenia, J., Aviv, H., Tsai, J. Y., Aisner, S., Cohen, S., Fernandes, H., Hameed, M: Oncoproteins and proliferation markers in synovial sarcoma. A clinicopathologic study of 17 cases. Journal of Cancer Research and Clinical Oncology, Vol 128, (11): 610-616, 2002

Barbashina V, Karabakhtsian R, Aisner S, Bolanowski P, Patterson F, Hameed M. Desmoplastic fibroma of the rib. Arch Pathol Lab Med. 2002 Jun;126(6):721-2.

Tsai JY, Aviv H, Benevenia J, Patterson F, Aisner S, Pliner L, Hameed M.: Prognostic Factors in Osteosarcoma – Role of Her2 /neu and P53: An Immunohistochemical (IHC) and Fluorescence in situ Hybridization (FISH) analysis. Cancer Investigation, Vol 22 (1) p16-24, 2004.

Hameed M, Lin TZ, Coffman F, CohenM, Fernandes H, Benevenia J, Patterson F, Aisner S and Stanley Cohen. Molecular markers in Osteosarcoma – A cDNA microarray and RT-PCR analysis. Journal of Musculoskeletal Research, Vol 9, No:2, p77-84, 2005

Hameed M. Small Round Cell Tumors of Bone. Review. Musculoskeletal Edition. Archives of Pathology and Laboratory Medicine, 131(2):192-204, 2007.

Hameed M. Pathology and Genetics of Adipocytic Tumors. Review. Cytogenetics and Genomic Research, Edited By Cannizzaro L.A and Ramesh K.H. Springer Verlag 2008.

Hameed M, Celal U, Duguyasa R, Limaye N, Kuvat R, Streck D, Dermodi J, Toruner G. Genome profiling of chondrosarcoma using oligonucleotide array based comparative genomic hybridization. Accepted for publication. Cancer, Genetics, Cytogenetics. Feb 2009.


Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.